Channel Therapeutics Corporation (CHRO)
Jul 2, 2025 - CHRO was delisted (reason: merged into PTHS)
13.50
0.00 (0.00%)
Inactive · Last trade price on Jul 1, 2025

Channel Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
94----
Enterprise Value
135----
Last Close Price
16.500.64----
PB Ratio
--1.42----
Debt / Equity Ratio
-0.60-0.80-0.20-0.15-0.30-0.07
Quick Ratio
0.030.130.020.02--
Current Ratio
0.180.340.020.02-0.02
Return on Assets (ROA)
-188.95%-645.79%-5663.30%---
Earnings Yield
-67.63%-205.89%----
Buyback Yield / Dilution
-173.25%-336.69%-193.25%---
Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q